about
Synergistic induction of apoptosis by combination of BTK and dual mTORC1/2 inhibitors in diffuse large B cell lymphoma.Effective combination therapies in preclinical endocrine resistant breast cancer models harboring ER mutations.AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies.Regulation of V-ATPase Assembly in Nutrient Sensing and Function of V-ATPases in Breast Cancer MetastasisIsoform-specific gene disruptions reveal a role for the V-ATPase subunit a4 isoform in the invasiveness of 4T1-12B breast cancer cellsAKT Ser/Thr kinase increases V-ATPase-dependent lysosomal acidification in response to amino acid starvation in mammalian cells
P50
description
researcher (ORCID 0000-0002-1806-6775)
@en
name
Michael Collins
@en
type
label
Michael Collins
@en
prefLabel
Michael Collins
@en
P31
P496
0000-0002-1806-6775